{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T12:37:09Z","timestamp":1782563829483,"version":"3.54.5"},"reference-count":42,"publisher":"Elsevier BV","issue":"25-26","license":[{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2004,9]]},"DOI":"10.1016\/j.vaccine.2004.02.036","type":"journal-article","created":{"date-parts":[[2004,5,11]],"date-time":"2004-05-11T13:11:27Z","timestamp":1084281087000},"page":"3348-3357","source":"Crossref","is-referenced-by-count":77,"title":["A DNA vaccine producing LcrV antigen in oligomers is effective in protecting mice from lethal mucosal challenge of plague"],"prefix":"10.1016","volume":"22","author":[{"given":"Shixia","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Destin","family":"Heilman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangjun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore","family":"Giehl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swati","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Te-hui","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon","family":"Goguen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2004.02.036_BIB1","unstructured":"http:\/\/www.csl.com.au\/."},{"issue":"10","key":"10.1016\/j.vaccine.2004.02.036_BIB2","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/S0264-410X(96)00303-9","article-title":"A sub-unit vaccine elicits IgG in serum, spleen cell cultures and bronchial washings and protects immunized animals against pneumonic plague","volume":"15","author":"Williamson","year":"1997","journal-title":"Vaccine"},{"issue":"4\u20135","key":"10.1016\/j.vaccine.2004.02.036_BIB3","first-page":"566","article-title":"A single dose sub-unit vaccine protects against pneumonic plague","volume":"19","author":"Williamson","year":"2001","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2004.02.036_BIB4","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1128\/CMR.10.1.35","article-title":"Yersinia pestis\u2013etiologic agent of plague","volume":"10","author":"Perry","year":"1997","journal-title":"Clin. Microbiol. Rev."},{"issue":"1","key":"10.1016\/j.vaccine.2004.02.036_BIB5","first-page":"75","article-title":"Antigen F1 from Yersinia pestis forms aqueous channels in lipid bilayer membranes","volume":"25","author":"Rodrigues","year":"1992","journal-title":"Braz. J. Med. Biol. Res."},{"issue":"3","key":"10.1016\/j.vaccine.2004.02.036_BIB6","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/infdis\/126.3.235","article-title":"Effects of fraction I from Yersinia pestis on phagocytosis in vitro","volume":"126","author":"Williams","year":"1972","journal-title":"J. Infect. Dis."},{"issue":"6","key":"10.1016\/j.vaccine.2004.02.036_BIB7","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1128\/IAI.64.6.2180-2187.1996","article-title":"Fraction 1 capsular antigen (F1) purification from Yersinia pestis CO92 and from an Escherichia coli recombinant strain and efficacy against lethal plague challenge","volume":"64","author":"Andrews","year":"1996","journal-title":"Infect Immun"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2004.02.036_BIB8","first-page":"223","article-title":"A new improved sub-unit vaccine for plague: the basis of protection, FEMS Immunol","volume":"12","author":"Williamson","year":"1995","journal-title":"Med. Microbiol."},{"issue":"5","key":"10.1016\/j.vaccine.2004.02.036_BIB9","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1128\/IAI.65.5.1926-1930.1997","article-title":"Expression of the Yersinia pestis capsular antigen (F1 antigen) on the surface of an aroA mutant of Salmonella typhimurium induces high levels of protection against plague","volume":"65","author":"Titball","year":"1997","journal-title":"Infect. Immun."},{"issue":"5","key":"10.1016\/j.vaccine.2004.02.036_BIB10","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1046\/j.1365-2958.1999.01408.x","article-title":"The V-antigen of Yersinia is surface exposed before target cell contact and involved in virulence protein translocation","volume":"32","author":"Pettersson","year":"1999","journal-title":"Mol Microbiol"},{"issue":"9","key":"10.1016\/j.vaccine.2004.02.036_BIB11","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1128\/jb.177.9.2530-2542.1995","article-title":"Differential effects of deletions in lcrV on secretion of V antigen, regulation of the low-Ca2+ response, and virulence of Yersinia pestis","volume":"177","author":"Skrzypek","year":"1995","journal-title":"J. Bacteriol."},{"issue":"9","key":"10.1016\/j.vaccine.2004.02.036_BIB12","doi-asserted-by":"crossref","first-page":"4801","DOI":"10.1128\/IAI.67.9.4801-4813.1999","article-title":"LcrV of Yersinia pestis enters infected eukaryotic cells by a virulence plasmid-independent mechanism","volume":"67","author":"Fields","year":"1999","journal-title":"Infect Immun"},{"issue":"8","key":"10.1016\/j.vaccine.2004.02.036_BIB13","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1128\/IAI.63.8.2854-2858.1995","article-title":"Active immunization with recombinant V antigen from Yersinia pestis protects mice against plague","volume":"63","author":"Leary","year":"1995","journal-title":"Infect. Immun."},{"issue":"5084","key":"10.1016\/j.vaccine.2004.02.036_BIB14","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1126\/science.1439793","article-title":"A surface protease and the invasive character of plague","volume":"258","author":"Sodeinde","year":"1992","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.vaccine.2004.02.036_BIB15","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1086\/315199","article-title":"Safety and immune responses to a DNA-based human immunodeficiency virus (HIV) type I env\/rev vaccine in HIV-infected recipients: follow-up data","volume":"181","author":"MacGregor","year":"2000","journal-title":"J. Infect. Dis."},{"issue":"7\u20138","key":"10.1016\/j.vaccine.2004.02.036_BIB16","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/S0264-410X(00)00302-9","article-title":"Induction of antigen-specific CD8+ T cells, T helper cells, and protective levels of antibody in humans by particle-mediated administration of a hepatitis B virus DNA vaccine","volume":"19","author":"Roy","year":"2000","journal-title":"Vaccine"},{"issue":"19","key":"10.1016\/j.vaccine.2004.02.036_BIB17","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1016\/S0264-410X(98)00180-7","article-title":"DNA vaccination with HIV-1 expressing constructs elicits immune responses in humans","volume":"16","author":"Ugen","year":"1998","journal-title":"Vaccine"},{"issue":"5388","key":"10.1016\/j.vaccine.2004.02.036_BIB18","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1126\/science.282.5388.476","article-title":"Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine","volume":"282","author":"Wang","year":"1998","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.vaccine.2004.02.036_BIB19","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/nm881","article-title":"Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans","volume":"9","author":"McConkey","year":"2003","journal-title":"Nat. Med."},{"issue":"25\u201326","key":"10.1016\/j.vaccine.2004.02.036_BIB20","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.1016\/S0264-410X(03)00362-1","article-title":"Comparison of individual and combination DNA vaccines for B. anthracis, Ebola virus, Marburg virus and Venezuelan equine encephalitis virus","volume":"21","author":"Riemenschneider","year":"2003","journal-title":"Vaccine"},{"issue":"7\u20138","key":"10.1016\/j.vaccine.2004.02.036_BIB21","first-page":"588","article-title":"Gene gun mediated vaccination is superior to manual delivery for immunisation with DNA vaccines expressing protective antigens from Yersinia pestis or Venezuelan Equine Encephalitis virus","volume":"18","author":"Bennett","year":"2000","journal-title":"Vaccine"},{"issue":"23\u201324","key":"10.1016\/j.vaccine.2004.02.036_BIB22","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1016\/S0264-410X(02)00232-3","article-title":"Co-immunisation with a plasmid DNA cocktail primes mice against anthrax and plague","volume":"20","author":"Williamson","year":"2002","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2004.02.036_BIB23","doi-asserted-by":"crossref","first-page":"3978","DOI":"10.1128\/JVI.70.6.3978-3991.1996","article-title":"Simian immunodeficiency virus DNA vaccine trial in macaques","volume":"70","author":"Lu","year":"1996","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.vaccine.2004.02.036_BIB24","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1006\/viro.1995.1238","article-title":"Use of DNAs expressing HIV-1 Env and noninfectious HIV-1 particles to raise antibody responses in mice","volume":"209","author":"Lu","year":"1995","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.vaccine.2004.02.036_BIB25","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1089\/aid.1998.14.151","article-title":"Immunogenicity of DNA vaccines expressing human immunodeficiency virus type 1 envelope glycoprotein with and without deletions in the V1\/2 and V3 regions","volume":"14","author":"Lu","year":"1998","journal-title":"AIDS Res. Hum. Retroviruses"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2004.02.036_BIB26","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1086\/514176","article-title":"DNA immunization for influenza virus: studies using hemagglutinin- and nucleoprotein-expressing DNAs","volume":"176","author":"Robinson","year":"1997","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2004.02.036_BIB27","doi-asserted-by":"crossref","unstructured":"Lu S, Manning S, Arthos J. Antigen engineering in DNA immunization. In: Lowrie DB, Whalen RG, edotors. Methods in molecular medicine, vol. 29. Totowa, NJ: Human Press Inc.; 1998. p. 355\u201374.","DOI":"10.1385\/1-59259-688-6:355"},{"issue":"19","key":"10.1016\/j.vaccine.2004.02.036_BIB28","doi-asserted-by":"crossref","first-page":"5192","DOI":"10.1128\/JB.180.19.5192-5202.1998","article-title":"Structural organization of virulence-associated plasmids of Yersinia pestis","volume":"180","author":"Hu","year":"1998","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2004.02.036_BIB29","first-page":"185","article-title":"Delivery of DNA to skin by particle bombardment","volume":"245","author":"Wang","year":"2004","journal-title":"Methods Mol Biol"},{"issue":"6","key":"10.1016\/j.vaccine.2004.02.036_BIB30","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1016\/S0006-3495(01)75981-4","article-title":"Probing molecular interactions in intact antibody: antigen complexes, an electrospray time-of-flight mass spectrometry approach","volume":"81","author":"Tito","year":"2001","journal-title":"Biophys. J."},{"issue":"5","key":"10.1016\/j.vaccine.2004.02.036_BIB31","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.4049\/jimmunol.158.5.2278","article-title":"Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization","volume":"158","author":"Feltquate","year":"1997","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.vaccine.2004.02.036_BIB32","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1128\/IAI.71.1.374-383.2003","article-title":"Effective protective immunity to Yrsinia pestis infection conferred by DNA vaccine coding for derivatives of the F1 capsular antigen","volume":"71","author":"Grosfeld","year":"2003","journal-title":"Infect. Immun."},{"issue":"5102","key":"10.1016\/j.vaccine.2004.02.036_BIB33","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1126\/science.8456302","article-title":"Heterologous protection against influenza by injection of DNA encoding a viral protein","volume":"259","author":"Ulmer","year":"1993","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.vaccine.2004.02.036_BIB34","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/8406","article-title":"Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations","volume":"5","author":"Robinson","year":"1999","journal-title":"Nat. Med."},{"issue":"11\u201312","key":"10.1016\/j.vaccine.2004.02.036_BIB35","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/S0264-410X(98)80110-2","article-title":"Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine","volume":"16","author":"Heath","year":"1998","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2004.02.036_BIB36","doi-asserted-by":"crossref","first-page":"4476","DOI":"10.1128\/IAI.65.11.4476-4482.1997","article-title":"Regions of Yersinia pestis V antigen that contribute to protection against plague identified by passive and active immunization","volume":"65","author":"Hill","year":"1997","journal-title":"Infect. Immun."},{"issue":"2","key":"10.1016\/j.vaccine.2004.02.036_BIB37","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1006\/viro.2000.0357","article-title":"The HIV-1 Env protein signal sequence retards its cleavage and down-regulates the glycoprotein folding","volume":"272","author":"Li","year":"2000","journal-title":"Virology"},{"issue":"3","key":"10.1016\/j.vaccine.2004.02.036_BIB38","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.4049\/jimmunol.168.3.1315","article-title":"Yersinia enterocolitica evasion of the host innate immune response by V antigen-induced IL-10 production of macrophages is abrogated in IL-10-deficient mice","volume":"168","author":"Sing","year":"2002","journal-title":"J. Immunol."},{"issue":"28","key":"10.1016\/j.vaccine.2004.02.036_BIB39","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1016\/S0264-410X(00)00128-6","article-title":"Protection studies following bronchopulmonary and intramuscular immunisation with yersinia pestis F1 and V subunit vaccines coencapsulated in biodegradable microspheres: a comparison of efficacy","volume":"18","author":"Eyles","year":"2000","journal-title":"Vaccine"},{"issue":"1\u20133","key":"10.1016\/j.vaccine.2004.02.036_BIB40","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0169-409X(01)00166-1","article-title":"Intranasal vaccination against plague, tetanus and diphtheria","volume":"51","author":"Alpar","year":"2001","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/j.vaccine.2004.02.036_BIB41","unstructured":"Williamson ED. The F1 + V combined sub-unit vaccine. In: NIH Plague Vaccine Meeting, Bethesda, MD, USA, 2002."},{"key":"10.1016\/j.vaccine.2004.02.036_BIB42","unstructured":"Adamovicz, J. Efficacy of the F1-V fusion protein vaccine in non-human primates. In: NIH Plague Vaccine Meeting 2002, Bethesda, MD, USA, November 22, 2002."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X04002099?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X04002099?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T16:37:15Z","timestamp":1682699835000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X04002099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":42,"journal-issue":{"issue":"25-26","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["S0264410X04002099"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2004.02.036","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,9]]}}}